Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
8 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Long-term survival after significant treatment reduction in a patient with CBF-AML.
Pediatr Blood Cancer. 2011 Feb;56(2):325-6. doi: 10.1002/pbc.22854. Epub 2010 Nov 11.
Pediatr Blood Cancer. 2011.
PMID: 21157900
No abstract available.
CBL mutations do not frequently occur in paediatric acute myeloid leukaemia.
Coenen EA, Driessen EM, Zwaan CM, Stary J, Baruchel A, de Haas V, de Bont ES, Reinhardt D, Kaspers GJ, Arentsen-Peters ST, Meyer C, Marschalek R, Pieters R, Stam RW, van den Heuvel-Eibrink MM.
Coenen EA, et al. Among authors: driessen em.
Br J Haematol. 2012 Dec;159(5):577-84. doi: 10.1111/bjh.12068. Epub 2012 Oct 1.
Br J Haematol. 2012.
PMID: 23025505
Free article.
Item in Clipboard
Frequencies and prognostic impact of RAS mutations in MLL-rearranged acute lymphoblastic leukemia in infants.
Driessen EM, van Roon EH, Spijkers-Hagelstein JA, Schneider P, de Lorenzo P, Valsecchi MG, Pieters R, Stam RW.
Driessen EM, et al.
Haematologica. 2013 Jun;98(6):937-44. doi: 10.3324/haematol.2012.067983. Epub 2013 Feb 12.
Haematologica. 2013.
PMID: 23403319
Free PMC article.
Item in Clipboard
Identification of genes transcriptionally responsive to the loss of MLL fusions in MLL-rearranged acute lymphoblastic leukemia.
van der Linden MH, Seslija L, Schneider P, Driessen EM, Castro PG, Stumpel DJ, van Roon E, de Boer J, Williams O, Pieters R, Stam RW.
van der Linden MH, et al. Among authors: driessen em.
PLoS One. 2015 Mar 20;10(3):e0120326. doi: 10.1371/journal.pone.0120326. eCollection 2015.
PLoS One. 2015.
PMID: 25793396
Free PMC article.
Item in Clipboard
Versican expression is an adverse prognostic factor in MLL-rearranged infant acute lymphoblastic leukaemia.
Driessen EM, Pinhanços SS, Schneider P, de Lorenzo P, Valsecchi MG, Pieters R, Stam RW.
Driessen EM, et al.
Eur J Cancer. 2016 Apr;57:87-90. doi: 10.1016/j.ejca.2015.12.031. Epub 2016 Feb 19.
Eur J Cancer. 2016.
PMID: 26901613
No abstract available.
Item in Clipboard
MEK inhibition is a promising therapeutic strategy for MLL-rearranged infant acute lymphoblastic leukemia patients carrying RAS mutations.
Kerstjens M, Driessen EM, Willekes M, Pinhanços SS, Schneider P, Pieters R, Stam RW.
Kerstjens M, et al. Among authors: driessen em.
Oncotarget. 2017 Feb 28;8(9):14835-14846. doi: 10.18632/oncotarget.11730.
Oncotarget. 2017.
PMID: 27588400
Free PMC article.
Item in Clipboard
Outcome of relapsed infant acute lymphoblastic leukemia treated on the interfant-99 protocol.
Driessen EM, de Lorenzo P, Campbell M, Felice M, Ferster A, Hann I, Vora A, Hovi L, Escherich G, Li CK, Mann G, Leblanc T, Locatelli F, Biondi A, Rubnitz J, Schrappe M, Silverman L, Stary J, Suppiah R, Szczepanski T, Valsecchi M, Pieters R.
Driessen EM, et al.
Leukemia. 2016 May;30(5):1184-7. doi: 10.1038/leu.2015.246. Epub 2015 Sep 15.
Leukemia. 2016.
PMID: 26369984
No abstract available.
Item in Clipboard
Outcome of relapsed infant acute lymphoblastic leukemia treated on the interfant-99 protocol.
Driessen EMC, de Lorenzo P, Campbell M, Felice M, Ferster A, Hann I, Vora A, Hovi L, Escherich G, Li CK, Mann G, Leblanc T, Locatelli F, Biondi A, Rubnitz J, Schrappe M, Silverman L, Stary J, Suppiah R, Szczepanski T, Valsecchi M, Pieters R.
Driessen EMC, et al.
Leukemia. 2017 Dec;31(12):2854. doi: 10.1038/leu.2017.279.
Leukemia. 2017.
PMID: 29210366
Item in Clipboard
Cite
Cite